Hans L Hillege
6PUBLICATIONS
42CO-AUTHORS

Get your video featured.

Get your video featured.
Publications (6)
Sort by Publication Date:
|Jul 24, 2023
The European Medicines Agency assessment of mavacamten as treatment of symptomatic obstructive hypertrophic cardiomyopathy in adult patients.J Hans DeVries, Alar Irs, Hans L Hillege
|May 20, 2023
A randomized controlled trial of eplerenone in asymptomatic phospholamban p.Arg14del carriers.Remco de Brouwer, Wouter P Te Rijdt, Edgar T Hoorntje
|Mar 01, 2023
Clinical utility of the 4S-AF scheme in predicting progression of atrial fibrillation: data from the RACE V study.Vicente Artola Arita, Martijn E Van De Lande, Neda Khalilian Ekrami
|Feb 15, 2023
What Factors Make EU Regulators Want to Communicate Drug Safety Issues Related to SGLT2 Inhibitors? An Online Survey Study.Sonia Roldan Munoz, Douwe Postmus, Sieta T de Vries
|Jul 13, 2019
The Clinical Value of Proposed Risk Stratification Tools in Pediatric Pulmonary Arterial Hypertension.Meindina G Haarman, Johannes M Douwes, Mark-Jan Ploegstra
Pageof 1
Frequent Collaborators
2 joint publications
Rudolf A de Boer
1 joint publications
Sonia Roldan Munoz
1 joint publications
Douwe Postmus
1 joint publications
Sieta T de Vries
1 joint publications
Liana Gross-Martirosyan
1 joint publications
Peter G M Mol
1 joint publications
Vicente Artola Arita
1 joint publications
Martijn E Van De Lande
1 joint publications
Bao-Oanh Nguyen
1 joint publications
Joost M Van Melle